Continuous dopaminergic stimulation for Parkinson's disease: facts and fancy.
Obeso
J A
JA
Department of Neurology, Universidad de Navarra, Pamplona, Spain.
Grandas
F
F
Vaamonde
J
J
Luquin
M R
MR
Martinez-Lage
J M
JM
D006801:Humans; D007980:Levodopa / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D009069:Movement Disorders / Q000139:chemically induced / Q000209:etiology*; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*
D007980:Levodopa